APOE and Alzheimer disease: Importantly, short-term treatment with an anti-inflammatory medical ketogenic diet in APOE ε4 carriers with AD partially reprogrammed this immune phenotype, reducing pro-inflammatory signaling and promoting regulatory and tissue-supportive immune functions.